
任何質(zhì)控物質(zhì)中的目標(biāo)核酸,無論是來自于患者樣品還是替代品(人工制造),都會隨著時間的推移而降解。由于核酸酶、凍融循環(huán)或其他影響,質(zhì)控物質(zhì)可能發(fā)生降解。一般來說,質(zhì)控物質(zhì)存檔的時間越長,樣品中可用的目標(biāo)核酸的數(shù)量就越少。根據(jù)對照品的穩(wěn)定性,可能需要定期開發(fā)新的對照或從制造商那里重新供應(yīng)對照。
參考文獻(xiàn)
[1] ISO. Medical devices – Application of risk management to medical devices. ISO 14971. Geneva, Switzerland: International Organization for Standardization; 2007.
[2] Millar BC, Xu J, Moore JE. Risk assessment models and contamination management: Implications for broad-range ribosomal DNA PCR as a diagnostic tool in medical bacteriology. J Clin Microbiol. 2002;40(5):1575-1580.
[3] Dowell SF, Peeling RW, Boman J, et al, and the C. pneumoniae workshop participants. Standardizing Chlamydia pneumoniae assays: Recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin Infec Dis. 2001;33(4):492-503.
郵政編碼:200052 電話:021-63800152 傳真:021-63800151 京ICP備15010734號-10 技術(shù):網(wǎng)至普網(wǎng)站建設(shè)